TY - JOUR
T1 - Effects of treatment status and life quality on anxiety in MMT patients
AU - Cao, Penghui
AU - Zhang, Zhaohua
AU - Zhong, Jun
AU - Xu, Shichao
AU - Huang, Qiaofang
AU - Fan, Ni
N1 - Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Background: Anxiety, an important factor that affects the therapeutic effect and preservation rate of methadone maintenance treatment, has a high prevalence among MMT patients. This study aims to investigate the effects of treatment status and life quality on anxiety in MMT patients. Methods: One hundred and Seventy-seven methadone maintenance treatment users in Guangzhou, China were evaluated. The socio-demographic, duration and MMT-related characteristics were documented. Anxiety level and quality of life were evaluated by Beck Anxiety inventory (BAI) and the Quality of Life-Drug Addiction (QOL-DA) respectively. The correlation between different factors and BAI score was also analyzed. Results: The BAI total score and the QOL-DA score were 7.1±8.2, 163.5±21.4 respectively. 30.5% of the subjects showed mild to severe anxiety. Treatment interruption and QOL-DA score had strong correlations with the score of BAI, with correlation coefficients of 0.17 and − 0.08 respectively. Conclusions: Anxiety symptoms were commonly presented in MMT patients. Treatment interruption and quality of life are two major factors affecting anxiety of MMT patients.
AB - Background: Anxiety, an important factor that affects the therapeutic effect and preservation rate of methadone maintenance treatment, has a high prevalence among MMT patients. This study aims to investigate the effects of treatment status and life quality on anxiety in MMT patients. Methods: One hundred and Seventy-seven methadone maintenance treatment users in Guangzhou, China were evaluated. The socio-demographic, duration and MMT-related characteristics were documented. Anxiety level and quality of life were evaluated by Beck Anxiety inventory (BAI) and the Quality of Life-Drug Addiction (QOL-DA) respectively. The correlation between different factors and BAI score was also analyzed. Results: The BAI total score and the QOL-DA score were 7.1±8.2, 163.5±21.4 respectively. 30.5% of the subjects showed mild to severe anxiety. Treatment interruption and QOL-DA score had strong correlations with the score of BAI, with correlation coefficients of 0.17 and − 0.08 respectively. Conclusions: Anxiety symptoms were commonly presented in MMT patients. Treatment interruption and quality of life are two major factors affecting anxiety of MMT patients.
KW - Anxiety
KW - Methadone maintenance treatment
KW - Quality of life
UR - http://www.scopus.com/inward/record.url?scp=85099403152&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85099403152&partnerID=8YFLogxK
U2 - 10.1186/s13011-021-00343-4
DO - 10.1186/s13011-021-00343-4
M3 - Article
C2 - 33441176
AN - SCOPUS:85099403152
SN - 1747-597X
VL - 16
JO - Substance Abuse: Treatment, Prevention, and Policy
JF - Substance Abuse: Treatment, Prevention, and Policy
IS - 1
M1 - 9
ER -